ERBB2 and neoplasm: The activity of caspase-3/7 increased significantly in miR-HER2-E1 exosome treatment HER2-positive tumor cell lines compared with the mock treatment (Mock) assessed by a Caspase® Glo 3/7 assay kit (Fig. 4b), suggesting that the cell undergoes apoptosis.